QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe 期刊论文 Journal of Experimental & Clinical Cancer Research, 2020, 卷号: 39, 期号: 1 作者:  Hu,Liangning;  Li,Bo;  Chen,Gege;  Song,Dongliang;  Xu,Zhijian 收藏  |  浏览/下载：94/0  |  提交时间：2020/07/01 Multiple myeloma  Drug-resistance  DNA damage response  Cell cycle   Proteasome Inhibition with Bortezomib Induces Apoptosis of Long-Lived Plasma Cells in Steroid-Resistant or Relapsed Immune Thrombocytopaenia 期刊论文 THROMBOSIS AND HAEMOSTASIS, 2018, 卷号: 118, 期号: 10, 页码: 1752-1764 作者:  Li, Guosheng;  Wang, Shuang;  Li, Na;  Liu, Yang;  Feng, Qi 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/11 proteasome inhibition  bortezomib  long-lived plasma cell  immune  thrombocytopaenia  apoptosis   The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells 期刊论文 ONCOLOGY REPORTS, 2017, 卷号: 38, 期号: 1, 页码: 488-496 作者:  Chen, Gege;  Xu, Zhijian;  Chang, Gaomei;  Hou, Jun;  Hu, Liangning 收藏  |  浏览/下载：24/0  |  提交时间：2019/01/08 pterostilbene  multiple myeloma  bortezomib-resistant cells  apoptosis  cell cycle  histone deacetylase inhibitors   Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line 期刊论文 MOLECULAR AND CELLULAR BIOCHEMISTRY, 2012, 卷号: 360, 期号: 1-2, 页码: 329-337 作者:  Lu, Jin-Jian 收藏  |  浏览/下载：12/0  |  提交时间：2019/01/08 Dihydroartemisinin  Resistant  Proteomics  Anti-tumor  HCT116   An investigation of reversal of imatinib resistance in the Bcr-Abl positive imatinib-resistant cell line K562r by dasatinib, nilotinib, rapamycin and bortezomib 期刊论文 FOCUS on News for You, 2010 - 收藏  |  浏览/下载：2/0  |  提交时间：2019/03/05 Antineoplastic  Agents/*pharmacology  Boronic  Acids/*pharmacology  Cell  Line,  Tumor  Cell  Proliferation/drug  effects  Drug  Resistance,  Neoplasm/*drug  effects  Fusion  Proteins,  bcr-abl/*metabolism  Humans  K562  Cells  Piperazines/*pharmacology  Pyrazines/*pharmacology  Pyrimidines/*pharmacology  Signal  Transduction/drug  effects  Sirolimus/*pharmacology  TOR  Serine-Threonine  Kinases/metabolism  Thiazoles/*pharmacology  Up-Regulation/drug  effects   Combined effects of lapatinib and bortezomib in human epidermal receptor 2 (HER2)-overexpressing breast cancer cells and activity of bortezomib against lapatinib-resistant breast cancer cells 期刊论文 CANCER SCIENCE, 2010, 卷号: 101, 期号: 10 作者:  Ma, Chuandong;  Niu, Xiuqing;  Luo, Jianmin;  Shao, Zhimin;  Shen, Kunwei 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19